In fact, MTT or Alamar blue cell viability assays showed comparable IC50 values between the two breast cancer cell-lines, MCF-7 (ER positive) and MDA-MB-231 (ER negative) 24 h after treatment with vernodalin (Figure 7 and S1B). The gene discussed is ESR1; the disease is breast carcinoma.